Risk factor
Very poor trading liquidity
Profitability factor
Strong margins and returns
About
PT Siloam International Hospitals Tbk, along with its affiliated entities, delivers comprehensive medical care throughout Indonesia. The company is also responsible for the establishment and ongoing management of hospital facilities. Its offerings span both general and specialized medical services, encompassing a wide range of treatments from intricate surgical procedures and emergency care to advanced diagnostic testing, laboratory analysis, and imaging services (radiology). The hospitals within its network boast expertise across numerous medical disciplines, including but not limited to pediatrics, neurology, ear, nose, and throat (ENT) care, general surgery, nephrology, cardiology, oncology, obstetrics and gynecology, gastroenterology, ophthalmology, pulmonology, internal medicine, orthopedics, urology, anesthesiology, dentistry, dermatology, geriatric and nuclear medicine, pathology, plastic surgery, and psychiatry. The group operates an extensive network of 40 hospitals, collectively providing 8,450 patient beds, strategically located across various Indonesian islands such as Sumatra, Java, Bali, Kalimantan, Sulawesi, Nusa Tenggara Timur, Nusa Tenggara Barat, and Bangka. Beyond its core healthcare provision, PT Siloam International Hospitals Tbk maintains a diverse portfolio of other commercial ventures. These include engagements in trading, property development, mining, agriculture, various service sectors, land transportation, general industry, workshop printing, plantation management, forestry, electrical and mechanical engineering, construction, agribusiness, and real estate. Furthermore, the company is involved in computer programming, management consulting, financial services (including trust and financing for financial entities), retail, professional, scientific, and technical activities, as well as the operation of web portals and digital platforms. Founded in 1996, the company, formerly known as PT Sentralindo Wirasta, maintains its headquarters in Tangerang, Indonesia.
Company Valuation
From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on E
Target Price
The average target price of SILO.JK is 3165 and suggests 42.6% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i